November, 2019 | The Wall Street Analyzer

Latest News

[ June 10, 2021 ] Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test Kit Now Available for Sale in US News Feed
[ June 9, 2021 ] GOLDEN INDEPENDENCE ANNOUNCES CLOSING OF PRIVATE PLACEMENT FINANCING News Feed
[ June 4, 2021 ] Ocuphire Announces $15 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules News Feed
[ June 4, 2021 ] City View Green Holdings Inc. and Budd Hutt Inc. Open Second Retail Cannabis Store in Grande Cache, Alberta News Feed
[ June 3, 2021 ] Golden Independence Announces Private Placement Financing News Feed
[ May 26, 2021 ] Citius Pharmaceuticals Selected to Receive Best Poster Award at the International Society for Cell and Gene Therapy 2021 Annual Meeting News Feed
[ May 19, 2021 ] Ocuphire Granted Two New U.S. Patents Covering Late-Stage Drug Candidate Nyxol®, Including for the Treatment of Presbyopia News Feed

Healthcare

True Nature Holding, Inc. (OTCQB: TNTY) CEO Interview

November 25, 2019 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

Mohawk Group Holdings (NASDAQ: MWK) CEO Interview

November 25, 2019 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

AquaBounty Technologies, Inc (NASDAQ: AQB) CEO Interview Series

November 22, 2019 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

Olympic Steel (NASDAQ: ZEUS) Management Interview

November 19, 2019 The Wall Street Analyzer Comments Off

THIS INTERVIEW HAS EXPIRED

News Feed

XpresSpa Announces Third Quarter 2019 Financial Results

November 15, 2019 The Wall Street Analyzer Comments Off

Continued traction in strengthening operations and financial performance
Comparable store sales increased 3.7%; Average sales per store increased 8.1%
Operating loss from continuing operations reduced by 36.4% over prior year period […]

News Feed

Soligenix Announces Recent Accomplishments And Third Quarter 2019 Financial Results

November 13, 2019 The Wall Street Analyzer Comments Off

Soligenix’s revenues for the quarter ended September 30, 2019 were $1.3 million as compared to $1.4 million for the quarter ended September 30, 2018. Revenues included payments on a contract in support of RiVax®, in addition to the grants received to support the development of SGX301 […]

News Feed

XpresSpa To Announce Third Quarter 2019 Financial Results on November 14, 2019

November 11, 2019 The Wall Street Analyzer Comments Off

NEW YORK, Nov. 11, 2019 (GLOBE NEWSWIRE) — XpresSpa Group Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”), today announced that it will report its third quarter 2019 financial results after the close of the financial […]

News Feed